Home - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group is a worldwide network of 1300 academic and community-based cancer centers and hospitals.| ECOG-ACRIN Cancer Research Group
The post The August 2025 <em>News from ECOG-ACRIN</em> blog is now available appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post The ECOG-ACRIN Clinical Research Associates (CRA) Core Committee is seeking candidates appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post Registration is now open for the Fall 2025 Group Meeting appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post Attention CRAs: Travel funds are available for the Fall 2025 Group Meeting (apply now) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post Attention APPs: Travel funds are available for the Fall 2025 Group Meeting (apply now) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post Attention radiation oncologists and trainees: Travel funds are available for the Fall 2025 Group Meeting (apply now) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post Mental health disparities persist 2 years after DCIS surgery (E4112) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post A new biomarker, KIM-1, may predict outcomes and response in kidney cancer (mentions E2805/ASSURE) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post Treatment headway gives much-needed hope in small-cell lung cancer (discusses EA5161 and other trials) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post Trial Spotlight: Dr. Ken Cardona gives an update on the STRASS 2 sarcoma trial (EA7211) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group is a worldwide network of 1300 academic and community-based cancer centers and hospitals.| ECOG-ACRIN Cancer Research Group
At #ASCO2025: 64% of early-stage HER2+, ER- breast cancer patients had a pCR with 12 weeks of THP. The CompassHER2 trial could change the chemo standard.#BreastCancer #OncoTwitter #ECOGACRIN #ClinicalResearch| ECOG-ACRIN Cancer Research Group
Group-wide meetings of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) occur twice a year and are open to researchers and staff affiliated with member institutions, patient advocates who are members of ECOG-ACRIN's various scientific committees, industry representatives, and invited individuals from external (non-member) organizations. Group meetings are closed to the public.| ECOG-ACRIN Cancer Research Group
Committee Purpose| ECOG-ACRIN Cancer Research Group
Description| ECOG-ACRIN Cancer Research Group
